PRC Clinical Galvanizes Brand

BURLINGAME, Calif.--(BUSINESS WIRE)-- PRC Clinical has galvanized its brand and website to reflect its increasingly specialized, high-touch approach to early phase clinical research. The vision of PRC showcases its commitment to providing customized CRO service for pharmaceutical, biotech and medical device sponsors.

“Since 2003, our experienced team has been providing a hands-on approach for trials because we understand that therapeutic areas like regenerative medicine, CNS and ophthalmology require exceptional attention to the study details,” said Curtis Head, CEO and co-founder of PRC Clinical. “We’re excited to have a new brand that reflects that level of focused attention.”

PRC Clinical works closely with industry sponsors to determine the most effective approach for study execution, required patient populations and logistics of early-phase and complex trials. Their veteran team of disease experts supplement sponsor teams, providing valuable data insights and scientific integrity through high quality trial deliverables.

“We’ve always provided the highest level of special handling for our clients with the overall goal of securing more patients for their trials,” said Tony Taricco, president, COO and co-founder of PRC Clinical. “And now our new look really emphasizes our continued dedication to providing the management and care our clients have come to expect from us to achieve this goal.”

For more information, visit prcclinical.com.

About PRC Clinical

PRC Clinical has specialized in providing specialty CRO services for more than 15 years. For biotech and pharmaceutical companies, our innovative approach to executing studies combines high-touch human elements and cutting-edge technology with extensive experience and deep therapeutic knowledge. PRC Clinical has specialized expertise across regenerative medicine, CNS, ophthalmology, pulmonary and COVID-19, rare and orphan disease and more complex indications.

Your clinical trial deserves TLC from PRC.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201006005291/en/